Where a veterinary medicinal product is intended for food-producing animal species, a marketing authorisation should only be granted if the pharmacologically active substances which the product contains are allowed in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council [Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (OJ L 152, 16.6.2009, p. 11).] and any acts adopted on the basis thereof for the animal species for which the veterinary medicinal product is intended.
Recital 24, Regulation (EU) 2019/6
In forcesince 11 Dec 2018
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…Law
Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009…Law
- celex=31990R2377
- celex=32001L0082
- num:eu=2001/82